Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,461.32
-17.3273-1.17%
Number of Gainers:- -
Number of Losers:7
Number of Flat:- -
PE:- -
High:1,478.75
Open:1,477.67
Low:1,451.29
Close:1,478.65
Volume:70.12M
Turnover:6.31B
Market Cap:1.53T
Float Cap:1.46T

Loading ...

UBS Remains a Hold on Novo Nordisk (0QIU)

TIPRANKS
·
2 hours ago

Novo Nordisk (0QIU) Gets a Buy from J.P. Morgan

TIPRANKS
·
2 hours ago

Rothschild & Co Redburn Adjusts PT on Eli Lilly to $875 From $830, Maintains Neutral Rating

MT Newswires Live
·
2 hours ago

Social Buzz: Wallstreetbets Stocks Mostly Lower Premarket Monday; Novo Nordisk, Strategy to Decline

MT Newswires Live
·
2 hours ago

Structure Therapeutics Inc expected to post a loss of 47 cents a share - Earnings Preview

Reuters
·
3 hours ago

Novo Nordisk announces REDEFINE 4 trial did not achieve primary endpoint

TIPRANKS
·
3 hours ago

Novo Nordisk's Obesity Drug Falls Short Against Eli Lilly's in Copenhagen Trial

Reuters
·
4 hours ago

Eli Lilly Shares Rise 2.1% Premarket After Novo Nordisk's Obesity Drug Falls Short Against Eli Lilly's in Copenhagen Trial

THOMSON REUTERS
·
4 hours ago

Viking Therapeutics Surges as Obesity Drug Hopes Rise

TIPRANKS
·
Feb 21

Novo Nordisk (0QIU) Receives a Buy from Kepler Capital

TIPRANKS
·
Feb 21

Amgen VP, Finance & CAO Matthew C. Busch Disposes of Common Shares

Reuters
·
Feb 21

NYSE Most Active Issues

Dow Jones
·
Feb 21

Eli Lilly & Co. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Feb 21

Analysts Offer Insights on Healthcare Companies: RxSight (RXST), Senseonics Holdings (SENS) and Novo Nordisk (NVO)

TIPRANKS
·
Feb 21

Novo Nordisk A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Feb 21

Pfizer Initiated at Underweight by Barclays

Dow Jones
·
Feb 20

Eli Lilly Initiated at Overweight by Barclays

Dow Jones
·
Feb 20

Amgen Initiated at Equal-Weight by Barclays

Dow Jones
·
Feb 20

Pfizer (PFE) Gets a Hold from Goldman Sachs

TIPRANKS
·
Feb 20

Eli Lilly Stock (LLY) Rises as Company Reports Progress with Crohn’s Disease Treatment

TIPRANKS
·
Feb 20